175 related articles for article (PubMed ID: 1369122)
1. Oligonucleotide therapy.
Crooke ST
Curr Opin Biotechnol; 1992 Dec; 3(6):656-61. PubMed ID: 1369122
[TBL] [Abstract][Full Text] [Related]
2. Progress in antisense oligonucleotide therapeutics.
Crooke ST; Bennett CF
Annu Rev Pharmacol Toxicol; 1996; 36():107-29. PubMed ID: 8725384
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide-based therapeutics for cancer.
Dean NM; Bennett CF
Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
[TBL] [Abstract][Full Text] [Related]
4. Antisense technology.
Crooke ST
Curr Opin Biotechnol; 1991 Apr; 2(2):282-7. PubMed ID: 1367866
[TBL] [Abstract][Full Text] [Related]
5. Progress toward oligonucleotide therapeutics: pharmacodynamic properties.
Crooke ST
FASEB J; 1993 Apr; 7(6):533-9. PubMed ID: 7682523
[TBL] [Abstract][Full Text] [Related]
6. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
Wagner A; Bock CT; Fechner H; Kurreck J
Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
[No Abstract] [Full Text] [Related]
7. Antisense strategies for oncogene inactivation.
Stein CA; Benimetskaya L; Mani S
Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
[TBL] [Abstract][Full Text] [Related]
8. Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo.
Wang L; Prakash RK; Stein CA; Koehn RK; Ruffner DE
Antisense Nucleic Acid Drug Dev; 2003; 13(3):169-89. PubMed ID: 12954117
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide technology in the development of cancer therapeutics.
Tseng BY; Brown KD
Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
[No Abstract] [Full Text] [Related]
10. Perspectives in antisense therapeutics.
Agrawal S; Iyer RP
Pharmacol Ther; 1997; 76(1-3):151-60. PubMed ID: 9535177
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
12. Technology evaluation: ISIS-2503, Isis Pharmaceuticals.
Morse MA
Curr Opin Mol Ther; 2001 Dec; 3(6):589-94. PubMed ID: 11804274
[TBL] [Abstract][Full Text] [Related]
13. Progress in antisense technology.
Crooke ST
Annu Rev Med; 2004; 55():61-95. PubMed ID: 14746510
[TBL] [Abstract][Full Text] [Related]
14. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform.
Bennett CF; Swayze EE
Annu Rev Pharmacol Toxicol; 2010; 50():259-93. PubMed ID: 20055705
[TBL] [Abstract][Full Text] [Related]
15. Medicinal chemistry of antisense oligonucleotides--future opportunities.
Cook PD
Anticancer Drug Des; 1991 Dec; 6(6):585-607. PubMed ID: 1772571
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.
Lu Y
Mini Rev Med Chem; 2006 Mar; 6(3):319-30. PubMed ID: 16515471
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
Mirabelli CK; Bennett CF; Anderson K; Crooke ST
Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke ST; Graham MJ; Zuckerman JE; Brooks D; Conklin BS; Cummins LL; Greig MJ; Guinosso CJ; Kornbrust D; Manoharan M; Sasmor HM; Schleich T; Tivel KL; Griffey RH
J Pharmacol Exp Ther; 1996 May; 277(2):923-37. PubMed ID: 8627575
[TBL] [Abstract][Full Text] [Related]
20. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.
Warzocha K; Wotowiec D
Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
